[
  {
    "ts": null,
    "headline": "CVS Health (CVS) Margin Miss Reinforces Debate Over Profitability Recovery Prospects",
    "summary": "CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...",
    "url": "https://finnhub.io/api/news?id=5df0ba574ccbd0f3f13e78ef66247732114573a8f5a2415168e7d1a8517be1cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761865880,
      "headline": "CVS Health (CVS) Margin Miss Reinforces Debate Over Profitability Recovery Prospects",
      "id": 137275163,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...",
      "url": "https://finnhub.io/api/news?id=5df0ba574ccbd0f3f13e78ef66247732114573a8f5a2415168e7d1a8517be1cb"
    }
  },
  {
    "ts": null,
    "headline": "CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results",
    "summary": "A strong quarter clouded by one costly accounting charge.",
    "url": "https://finnhub.io/api/news?id=8fe7ce1294921ce8139021d5e56b0ffb55794d8fb82c881feb2a2a10becbe373",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761861106,
      "headline": "CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results",
      "id": 137275164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "A strong quarter clouded by one costly accounting charge.",
      "url": "https://finnhub.io/api/news?id=8fe7ce1294921ce8139021d5e56b0ffb55794d8fb82c881feb2a2a10becbe373"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
    "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
    "url": "https://finnhub.io/api/news?id=c3e1b69222ea593b36e75e45576111b75f94ed015fa39bacf2080ff8b71f0db9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761857100,
      "headline": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
      "id": 137275126,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
      "url": "https://finnhub.io/api/news?id=c3e1b69222ea593b36e75e45576111b75f94ed015fa39bacf2080ff8b71f0db9"
    }
  },
  {
    "ts": null,
    "headline": "Why CVS Health (CVS) Stock Is Falling Today",
    "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.",
    "url": "https://finnhub.io/api/news?id=585c3306be1bcc2bc7f89ad3c6d8bd75e217666a6b77b8a4481c485d4a507121",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761852943,
      "headline": "Why CVS Health (CVS) Stock Is Falling Today",
      "id": 137269255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.",
      "url": "https://finnhub.io/api/news?id=585c3306be1bcc2bc7f89ad3c6d8bd75e217666a6b77b8a4481c485d4a507121"
    }
  },
  {
    "ts": null,
    "headline": "Meta Looks to Raise at Least $25 Billion From Bond Sale",
    "summary": "The anticipated size, which was according to people familiar with the matter, would make Meta’s deal one of the largest of 2025.  This year’s largest public investment-grade note sale was the $26 billion raised in March by Mars Inc., a candy maker, to help finance its purchase of Kellanova, a snack food company.  Meta is looking to issue notes in as many as six parts, ranging from five to 40 years in length, according to a person familiar with the matter who asked not to be identified as they’re not authorized to speak publicly.",
    "url": "https://finnhub.io/api/news?id=bcac45fdbd498ed04a8861eea7b7c2808e540b0c703e9bba4b921fc687e67d0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761831455,
      "headline": "Meta Looks to Raise at Least $25 Billion From Bond Sale",
      "id": 137266418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The anticipated size, which was according to people familiar with the matter, would make Meta’s deal one of the largest of 2025.  This year’s largest public investment-grade note sale was the $26 billion raised in March by Mars Inc., a candy maker, to help finance its purchase of Kellanova, a snack food company.  Meta is looking to issue notes in as many as six parts, ranging from five to 40 years in length, according to a person familiar with the matter who asked not to be identified as they’re not authorized to speak publicly.",
      "url": "https://finnhub.io/api/news?id=bcac45fdbd498ed04a8861eea7b7c2808e540b0c703e9bba4b921fc687e67d0d"
    }
  },
  {
    "ts": null,
    "headline": "Meta’s bond sale reportedly attracts record $125 billion in orders",
    "summary": "Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.",
    "url": "https://finnhub.io/api/news?id=a0c005d1e4a028fc753fbf61587710ee51d15e7fe30e180f0d929cc4131e09cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761845120,
      "headline": "Meta’s bond sale reportedly attracts record $125 billion in orders",
      "id": 137268614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.",
      "url": "https://finnhub.io/api/news?id=a0c005d1e4a028fc753fbf61587710ee51d15e7fe30e180f0d929cc4131e09cc"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health's 'Strong' Q3 Performance Supports Leading Position as Medicare Advantage Carrier, RBC Says",
    "summary": "CVS Health's (CVS) \"strong\" Q3 performance reinforces the company's position as a leading Medicare A",
    "url": "https://finnhub.io/api/news?id=92a11ef1319edd5a85757cbd8cd2f4d84ec4be7554f5027ca51c19678988aefb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761839637,
      "headline": "CVS Health's 'Strong' Q3 Performance Supports Leading Position as Medicare Advantage Carrier, RBC Says",
      "id": 137268929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health's (CVS) \"strong\" Q3 performance reinforces the company's position as a leading Medicare A",
      "url": "https://finnhub.io/api/news?id=92a11ef1319edd5a85757cbd8cd2f4d84ec4be7554f5027ca51c19678988aefb"
    }
  },
  {
    "ts": null,
    "headline": "Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services",
    "summary": "The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.",
    "url": "https://finnhub.io/api/news?id=c5ac7d4bd0c37291e4a51d97cad916726c3d06c604aa10fe27977af6752f6a9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761835920,
      "headline": "Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services",
      "id": 137268756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.",
      "url": "https://finnhub.io/api/news?id=c5ac7d4bd0c37291e4a51d97cad916726c3d06c604aa10fe27977af6752f6a9a"
    }
  },
  {
    "ts": null,
    "headline": "My Top 10 High-Yield Picks For November 2025: One Yields 9%+",
    "summary": "These top high-yield dividend stocks provide income and growth. Learn how diversified picks like CVX, VZ, MO & ARCC can boost your portfolio.",
    "url": "https://finnhub.io/api/news?id=4cf18d02d9223cc08fd54110f96b4d4a127794abbdac2cc5f945fe2901caa4dc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761831217,
      "headline": "My Top 10 High-Yield Picks For November 2025: One Yields 9%+",
      "id": 137268228,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458260449/image_458260449.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "These top high-yield dividend stocks provide income and growth. Learn how diversified picks like CVX, VZ, MO & ARCC can boost your portfolio.",
      "url": "https://finnhub.io/api/news?id=4cf18d02d9223cc08fd54110f96b4d4a127794abbdac2cc5f945fe2901caa4dc"
    }
  },
  {
    "ts": null,
    "headline": "Americans in their 30s, 40s are getting richer faster than boomers — here’s how they’re outpacing their parents",
    "summary": "It's a turnaround for the 'broke' generation.",
    "url": "https://finnhub.io/api/news?id=955a7e5a6ba7a240664c9fa3355c4a54f0e6bc69208d29af80c3fc9920463789",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761822660,
      "headline": "Americans in their 30s, 40s are getting richer faster than boomers — here’s how they’re outpacing their parents",
      "id": 137266537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "It's a turnaround for the 'broke' generation.",
      "url": "https://finnhub.io/api/news?id=955a7e5a6ba7a240664c9fa3355c4a54f0e6bc69208d29af80c3fc9920463789"
    }
  },
  {
    "ts": null,
    "headline": "CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook",
    "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=2a0f9a89c6bb9a5c20b443388a4d83040824cc2fd60c4b0160fdee480f1c9e72",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761802421,
      "headline": "CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook",
      "id": 137266755,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=2a0f9a89c6bb9a5c20b443388a4d83040824cc2fd60c4b0160fdee480f1c9e72"
    }
  },
  {
    "ts": null,
    "headline": "UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target",
    "summary": "CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]",
    "url": "https://finnhub.io/api/news?id=ca5d6423bb082bda03c4c478dfd9b080978be9eb96152231e3662bc5c41245e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761789781,
      "headline": "UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target",
      "id": 137263748,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]",
      "url": "https://finnhub.io/api/news?id=ca5d6423bb082bda03c4c478dfd9b080978be9eb96152231e3662bc5c41245e4"
    }
  }
]